Meltem Ekenel

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

Neoadjuvant Therapy, Chemotherapy Versus Cetuximab, Medicine +7

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Capecitabine Therapy of Central Nervous System Metastases from Breast Cancer

Meltem Ekenel, Adı́lia Hormigo, Scott Peak et al. · Journal of Neuro-Oncology · 2007 · 157 citations

Neuro-oncology, Breast Oncology, Medicine +5

HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples.

Mahmut Gümüş, Perran Fulden Yumuk, Taflan Salepçi et al. · PubMed · 2006 · 98 citations

Tumoral Tissue Samples, Viral Diagnostics, Immunology +16